UBS downgrades Zurich Insurance Group to 'Sell'
ZURICH (dpa-AFX Analyst) - Swiss major bank UBS has maintained a "sell" rating on Zurich after an in-house industry event, with a price target of CHF 535. Investors at the Swiss insurer have been focused on margin development in light of declining prices for large corporate risks, Will Hardcastle wrote on Thursday. Maintaining margins in this area is apparently a challenge./gl/ag Publication of the original study: July 10, 2025 / 2:13 p.m. / GMT First distribution of the original study: July 10, 2025 / 2:13 p.m. / GMT Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
ISIN: CH0011075394
© 2025 dpa-AFX-Analyser
Hensoldt, Renk & Rheinmetall expensive
Rheinmetall, Renk, and Hensoldt have dominated the arms boom of recent years, but these stocks are now fundamentally hopelessly overvalued. P/E ratios exceed 60, price-to-sales ratios exceed 4, and this in a politically fragile environment with shaky fiscal discipline. This can be expensive for late-entering investors. But there are alternatives that have so far flown under the radar: solidly valued, operationally strong, and with catch-up potential. In our free report, we show you which three arms companies still have potential and how you can profit from the second wave of the turning point without getting burned by overheated high-flyers. Get the latest report! Don't miss out on which stocks are particularly likely to benefit from the global arms buildup and download the free PDF now.
This exclusive offer is only valid for a limited time! So download it now!
nachrichten-aktien-europa
